What is the current evidence on lung cancer screening?
– How can risk prediction and biomarkers contribute to make lung cancer screening more effective and efficient?
– What role could artificial intelligence play in lung cancer screening?
CHAIR: Dr Rosa Giuliani, Consultant in Medical Oncology, Clatterbridge Cancer Centre, United Kingdom, and Director of Public Policy, European Society for Medical Oncology (ESMO)
– Professor Joachim Aerts, Head, Department of Pulmonary Medicine, Erasmus University Medical Center, Netherlands
– Dr Hilary Robbins, Scientist, Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
To register click here.